Jump to navigation
Although the cannabis industry is the fastest growing industry in the world, investors need to be selective and conduct thorough due diligence before investing.
When it comes to the cannabis industry, it all starts with the management team and it is important than ever to know who you are investing in.
Canadian licensed medical marijuana producers were under pressure yesterday and we are monitoring how this trend continues today.
Although we have been favorable on this rally, we expressed some of our near-term concerns earlier this week as these stocks were trading at very overbought levels.
Following yesterday’s pullback, several medical marijuana producers under our coverage are no longer trading at overbought levels and we are favorable on this dip.
Reliq Health Technologies (RHT.V) (RQHTF) has been nothing short of an execution story and we have been calling for this all year.
Today, Reliq announced that it has received the first payment of $200,000 from NextGen Applications LLC of San Antonio, Texas. This payment is part of the contract between the two companies and the contract has a total value of $1.22 million (USD).
Canadian marijuana stocks have been on fire and this rally has shown no signs of slowing down.
The recent rally has taken place on strong trading volume and we are very favorable on this. One of the biggest changes from the first quarter to the second and third quarters of this year was trading volume. Although this metric was consistently increasing in the early months of 2017, it started to drop off in March/April.
Eaze, the leading cannabis technology company, announced today an additional $27 million in Series B financing, led by Bailey Capital with participation from DCM Ventures, Kaya Ventures and FJ Labs.
Political Analyst – Derek Thomas
Sen. Cory Booker, a democrat from New Jersey, has introduced a Hail Mary of a bill that, if passed, would actually incentivize states to legalize marijuana. In total, the bill would remove cannabis from the drug schedule completely, encourage states to legalize it, punish states that don’t, and work to fix some of the past injustices done to Americans over marijuana possession and other marijuana charges.
Earnings season has started to heat up and marijuana stock investors have a lot to catch up on this morning.
After the market closed yesterday, licensed medical marijuana producers Cronos Group and Emblem Corp. reported earnings and we have provided a recap on these results. We have also provided an update on CannTrust after the company reported strong numbers yesterday.
Cronos Group: Revenue Grew 25% Over the Prior Quarter
Although the growing and selling of marijuana remains the sexiest opportunity in the legal medical marijuana industry, we continue to see the most potential on the biotech side of the industry.
Biotech companies focused on medical marijuana possess the greatest upside potential as they work to develop treatments derived from marijuana, which can be used to improve daily life for millions of people throughout the world.
Although the legal marijuana industry continues to attract new investors, many do not have access to the information they need to make educated investment decisions.
While we are favorable on the legal marijuana market in the United States, we feel more secure investing in countries where the government has made the cultivation and selling of medical marijuana legal.
Processing, please wait. This may take up to 15 seconds to complete.
Please do not close your browser.